Concepedia

Parisa Rezaeifar

PR

Statistics

Publications

10

Citations

357

H-Index

10

Active since

2007

Affiliations

Tabriz University of Medical Sciences(Current)

Tehran University of Medical Sciences

University of Liverpool

Universidad Católica de Murcia

Rasool Akram Hospital

Parisa Rezaeifar is an author at Tabriz University of Medical Sciences specializing in medicine, health policy, and geriatric oncology.

ORCID

Top concepts

Publications per year

2007–2021

10

Publications

10

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis Research · 2020 · 84 citations · Full text

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 78 citations · Full text

Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study

Farid Rashidi, Stefano Barco, Farin Kamangar et al. · Thrombosis Research · 2020 · 72 citations · Full text

Bone density and bone metabolism in patients with inflammatory bowel disease

Parisa Rezaeifar, k mosnati shirazi, MohammadH Somi et al. · Saudi Journal of Gastroenterology · 2012 · 24 citations · Full text

The early start of hemoperfusion decreases the mortality rate among severe <scp>COVID</scp>‐19 patients: A preliminary study

Haleh Mikaeili, Ali Taghizadieh, Masoud Nazemiyeh et al. · Hemodialysis International · 2021 · 20 citations

Rows per page

1–5 of 10